Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for new vaccines against tuberculosis

I M Orme1

  • 1Dept of Microbiology, Colorado State University, Fort Collins 80523, USA.

Trends in Microbiology
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of lesion volume by MRI and stereology in a macaque model of tuberculosis.

Tuberculosis (Edinburgh, Scotland)·2009
Same author

Animal models of mycobacteria infection.

Current protocols in immunology·2008
Same author

Gamma interferon production by bovine gamma delta T cells following stimulation with mycobacterial mycolylarabinogalactan peptidoglycan.

Infection and immunity·2004
Same author

Toll-like receptor 4 plays no role in susceptibility of mice to Mycobacterium tuberculosis infection.

Tuberculosis (Edinburgh, Scotland)·2003
Same author

The mouse as a useful model of tuberculosis.

Tuberculosis (Edinburgh, Scotland)·2003
Same author

Activation marker expression on bovine peripheral blood gammadelta T cells during post-natal development and following vaccination with a commercial polyvalent viral vaccine.

Developmental and comparative immunology·2003
Same journal

Host membranes provide hidden gateways for 'accidental pathogens'.

Trends in microbiology·2026
Same journal

Structural inequalities in global antimicrobial resistance governance.

Trends in microbiology·2026
Same journal

Environmental microbes as modulators of plant volatile landscapes: Implications for plant-insect chemical communication.

Trends in microbiology·2026
Same journal

Beyond AMGs: Phage-encoded transcription and sigma factors as understudied virocell reprogramming tools.

Trends in microbiology·2026
Same journal

Cronobacter spp.

Trends in microbiology·2026
Same journal

Anaerobic lignin deconstruction: A game changer for lignocellulosic biorefineries.

Trends in microbiology·2026
See all related articles

The current tuberculosis vaccine, bacille Calmette-Guérin (BCG), has failed in trials. New strategies involve modifying BCG or developing subunit vaccines from Mycobacterium tuberculosis proteins.

Area of Science:

  • Immunology
  • Microbiology
  • Vaccinology

Background:

  • The bacille Calmette-Guérin (BCG) vaccine, the only licensed tuberculosis vaccine, has shown limited efficacy in preventing adult pulmonary tuberculosis.
  • Recent tuberculosis-control trials have highlighted the spectacular failure of the existing BCG vaccine, necessitating the development of improved tuberculosis vaccines.

Purpose of the Study:

  • To explore novel strategies for developing effective tuberculosis vaccines.
  • To investigate alternative approaches beyond the traditional BCG vaccine for tuberculosis control.

Main Methods:

  • Modulation of BCG through the production of auxotrophic mutants.
  • Development of recombinant BCG strains secreting cytokines.
  • Creation of subunit vaccines utilizing major proteins from Mycobacterium tuberculosis.

Related Experiment Videos

Main Results:

  • Exploration of auxotrophic mutants for potential BCG modulation.
  • Investigation of cytokine-secreting recombinants for enhanced immune response.
  • Development of subunit vaccines targeting key Mycobacterium tuberculosis antigens.

Conclusions:

  • Innovative strategies are crucial to overcome the limitations of the current BCG vaccine.
  • Modulating BCG and developing novel subunit vaccines represent promising avenues for future tuberculosis vaccine development.